Potential differentiation of islet-like cells from pregnant cow-derived placental stem cells
Type 1 diabetes is an autoimmune disease that destroys islet cells and results in insufficient insulin secretion by pancreatic β-cells. Islet transplantation from donors is an approach used for treating patients with diabetes; however, this therapy is difficult to implement because of the lack of donors. Nevertheless, several stem cells have the potential to differentiate from islet-like cells and enable insulin secretion for treating diabetes in animal models. For example, placenta is considered a waste material and can be harvested noninvasively during delivery without ethical or moral concerns.
Source: Taiwanese Journal of Obstetrics and Gynecology - Category: OBGYN Authors: Shao-Yu Peng, Chien-wen Chou, Yu-Hsuan Kuo, Perng-Chih Shen, S.W. Steven Shaw Tags: Original Article Source Type: research
More News: Autoimmune Disease | Diabetes | Diabetes Type 1 | Endocrinology | Insulin | Medical Ethics | OBGYN | Pancreas | Pregnancy | Stem Cell Therapy | Stem Cells | Transplants